This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024
Secure Your Spot
Menu
BOOK NOW

Eric Smith
Executive Director - Bispecifics at Regeneron Pharmaceuticals
Speaker

Profile

Dr. Eric Smith received his Ph.D. in Microbiology and Immunology from Duke University in 1997. Following a postdoctoral fellowship at NYU he joined Regeneron in 2002 as a member of the Antibody and Trap Technologies group, where he worked on cytokine traps and related molecules. In 2008 he was a founding member of the Bispecific Antibodies team and is currently the Sr. Director of Bispecifics at Regeneron.

Agenda Sessions

  • Co-Chairs’ Remarks - Innovative Concepts in Cell Engagers

    , 2:25pm
    View Session

  • Combination Strategies to Enhance Anti-tumor T cell Response

    , 2:30pm
    View Session

At this event

Prev
Next
Jonathan Sockolosky, PhD
Senior Director, CSO Partner Team
Curie.Bio

See Eric at Antibody Engineering & Therapeutics US

Secure Your Spot